Patent · US Active

Sultam compound and application method thereof

US11111240B2 · kind B2 · utility

0Cited by

0References

20Claims

0Family size

Assignees

Inventors

Li Zhu · Shanghai, CN
Xiaowei Duan · Beijing, CN
Liguang Dai · Beijing, CN
Zhao Yang · Beijing, CN
Yanqing Yang · Beijing, CN
Hui Zhang · Jinan, CN
Yuandong Hu · Beijing, CN
Yong Peng · Beijing, CN
Yongxin Han · Kirkland, CA
Rui Zhao · Beijing, CN
Xin Tian · 安丰镇, CN
Shanchun Wang · 安丰镇, CN

Key dates

Filing date	Mar 22, 2017
Grant date	Sep 7, 2021
Priority date	—
Expiry date	May 15, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are a sultam compound having isocitrate dehydrogenase 1 (IDH1) inhibitory activity as represented by formula I or pharmaceutically-acceptable salts, solvates or hydrates thereof, a preparation method thereof, and a pharmaceutical composition containing the compound. The compound or the pharmaceutically-acceptable salts, solvates or hydrates thereof, and the pharmaceutical composition containing the compound can be used to treat IDH1 mutation-induced cancers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.